Clinical Characteristics of Patients Subjected to Analysis
| Patient No. . | Age/Sex . | Platelet . | Serum TPO Level (fmol/mL) . | Duration of the Disease (yr) . | Symptoms . | Treatment . |
|---|---|---|---|---|---|---|
| . | . | (×103/μL) . | . | . | . | . |
| 1 | 38/F | 609 | 0.78 | 2 | ( — ) | ( — ) |
| 2 | 67/F | 1112 | ND | 0.5 | ( — ) | ( — ) |
| 3 | 18/M | 1512 | 0.66 | 1 | ( — ) | Aspirin |
| 4 | 54/F | 728 | 0.60 | 4 | ( — ) | Hydroxyurea |
| 5 | 60/F | 850 | 0.50 | 10 | Angina | Aspirin |
| 6 | 50/F | 1015 | 0.41 | 6 | ( — ) | Aspirin |
| 7 | 55/M | 988 | 5.20 | 10 | Angina | Hydroxyurea |
| 8 | 75/F | 1300 | 0.70 | 3 | ( — ) | Ticlopidine |
| 9 | 75/M | 769 | 4.60 | 24 | AMI | Ticlopidine |
| 10 | 48/F | 624 | 1.60 | 4 | ( — ) | Hydroxyurea, Aspirin |
| 11 | 38/F | 1239 | 1.08 | 1 | ( — ) | Hydroxyurea, Aspirin |
| 12 | 79/F | 750 | 0.22 | 8 | Bleeding tendency | Hydroxyurea |
| 13 | 64/M | 794 | 0.35 | 9 | TIA | Hydroxyurea |
| 14 | 46/F | 716 | 0.39 | 5 | TIA | Hydroxyurea, Aspirin, Ticlopidine |
| 15 | 67/F | 539 | ND | 2 | Genital bleeding | Hydroxyurea |
| 16 | 35/M | 2000 | ND | 1 | ( — ) | ( — ) |
| 17 | 81/M | 776 | ND | 5 | Angina | Ticlopidine |
| CML | 46/M | 962 | 0.10 | 0.5 | ( — ) | ( — ) |
| Patient No. . | Age/Sex . | Platelet . | Serum TPO Level (fmol/mL) . | Duration of the Disease (yr) . | Symptoms . | Treatment . |
|---|---|---|---|---|---|---|
| . | . | (×103/μL) . | . | . | . | . |
| 1 | 38/F | 609 | 0.78 | 2 | ( — ) | ( — ) |
| 2 | 67/F | 1112 | ND | 0.5 | ( — ) | ( — ) |
| 3 | 18/M | 1512 | 0.66 | 1 | ( — ) | Aspirin |
| 4 | 54/F | 728 | 0.60 | 4 | ( — ) | Hydroxyurea |
| 5 | 60/F | 850 | 0.50 | 10 | Angina | Aspirin |
| 6 | 50/F | 1015 | 0.41 | 6 | ( — ) | Aspirin |
| 7 | 55/M | 988 | 5.20 | 10 | Angina | Hydroxyurea |
| 8 | 75/F | 1300 | 0.70 | 3 | ( — ) | Ticlopidine |
| 9 | 75/M | 769 | 4.60 | 24 | AMI | Ticlopidine |
| 10 | 48/F | 624 | 1.60 | 4 | ( — ) | Hydroxyurea, Aspirin |
| 11 | 38/F | 1239 | 1.08 | 1 | ( — ) | Hydroxyurea, Aspirin |
| 12 | 79/F | 750 | 0.22 | 8 | Bleeding tendency | Hydroxyurea |
| 13 | 64/M | 794 | 0.35 | 9 | TIA | Hydroxyurea |
| 14 | 46/F | 716 | 0.39 | 5 | TIA | Hydroxyurea, Aspirin, Ticlopidine |
| 15 | 67/F | 539 | ND | 2 | Genital bleeding | Hydroxyurea |
| 16 | 35/M | 2000 | ND | 1 | ( — ) | ( — ) |
| 17 | 81/M | 776 | ND | 5 | Angina | Ticlopidine |
| CML | 46/M | 962 | 0.10 | 0.5 | ( — ) | ( — ) |
Abbreviations: ND, not done; AMI, acute myocardial infarction; TIA, transient ischemic attack.